Fresnillo plc posted its best first-half financial results in 18 years, driven by high precious metals prices and operational efficiency. The company reported earnings per share of $1.75 and revenue of $3.413 billion, both surpassing analyst expectations. Despite lower sales volumes, higher metal prices and lower operating costs boosted performance. Fresnillo also generated $1.257 billion in free cash flow and maintains a strong balance sheet with a low debt-to-equity ratio of 0.18 and a current ratio of 4.35, indicating solid financial health.
Stocks fell sharply due to various factors including a 58.71% drop in the Defiance Daily Target 2x Short PLTR ETF, driven by strong gains in Palantir Technologies, which the ETF inversely tracks. AdaptHealth shares dropped 38.09% amid a legal investi...
Pomerantz LLP is investigating Karyopharm Therapeutics for potential securities fraud related to a retention program granting top executives lump sum cash bonuses between $625,000 and $1,725,000. The announcement led to a 21.45% drop in Karyopharm's ...
LiveOne announced it will release its first quarter fiscal 2027 financial results on August 12, 2026, with a conference call to discuss the performance. The company expects continued year-over-year growth in revenue and adjusted EBITDA, driven by org...
Immix Biopharma appointed Richard Graydon as Chief Medical Officer in March 2026, but he was terminated in July after it was revealed he was actually Ronald L. Fischer, a fugitive wanted since 2005 for rape charges. This revelation led to a 14.15% dr...
Robert W. Baird lowered its price target for Fidelity National Information Services (FIS) from $54.00 to $48.00 following the company's mixed Q2 2026 earnings report. FIS posted strong adjusted EPS of $1.48, beating estimates and showing 8.8% growth ...
